Zilico Company

Zilico is focused on developing next generation cancer diagnostics to provide real-time diagnosis for cervical cancer.
Technology: Biomarkers of Female Cancers
Industry: Deep diagnostics
Headquarters: Manchester, Manchester, United Kingdom
Founded Date: 2006-01-01
Employees Number: 11-50
Funding Status: Corporate Round
Investors Number: 8
Total Funding: $24 M
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-02-04
Last Funding Type: Corporate Round

Visit Website
info@zilico.co.uk
https://twitter.com/zilicoltd
Register and Claim Ownership